Improvement in aging appearance, social confidence, and psychological well-being with combined facial aesthetic treatment comprising onabotulinumtoxinA, dermal fillers, and bimatoprost: HARMONY study outcomes - 21/04/16
Steven Dayan, MD, DeNova Research, Chicago, IL, United States; Susan H. Weinkle, MD, private practice, Bradenton, FL, United States; Joel L. Cohen, AboutSkin Dermatology and DermSurgery, Englewood, CO, United States; Michael S. Kaminer, MD, SkinCare Physicians, Chestnut Hill, MA, United States; Vic Narurkar, MD, Bay Area Laser Institute, San Francisco, CA, United States; Alexander Rivkin, MD, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States; Ava Shamban, MD, Ava MD, Beverly Hills, CA, United States; Jonathan M. Sykes, MD, UC Davis Medical Group, Sacramento, CA, United States; Craig Teller, MD, private practice, Bellaire, TX, United States; William P. Werschler, MD, Spokane Dermatology Clinic, Werschler Aesthetics, Premier Clinical Research, Spokane, WA, United States; Conor J. Gallagher, PhD, Allergan, Inc, Irvine, CA, United States
Le texte complet de cet article est disponible en PDF. Supported by Allergan, Inc. |
Vol 74 - N° 5S1
P. AB18 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?